WBR0085
Jump to navigation
Jump to search
| Author | Aditya Govindavarjhulla |
|---|---|
| Exam Type | USMLE Step 2 CK |
| Main Category | Pediatrics |
| Sub Category | Pediatrics, Infectious Disease |
| Prompt | A 26 year old mother was seen by an Infectious disease consult team on the 2 second day after delivery. She has positive test results for VDRL and FTA-ABS. Which test should be ordered by the team before starting treatment in the infant? |
| Answer A | Maternal serum – VDRL |
| Answer A Explanation | Quantitative tests must be performed on infants born to reactive mothers, rather than testing the mother. |
| Answer B | Infant serum – VDRL |
| Answer B Explanation | Infant serum-VDRL is a quantitative non-treponemal serologic test. Infant serum VDRl or RPR should be performed on infants born to reactive mothers. |
| Answer C | Umbilical cord – VDRL |
| Answer C Explanation | Umbilical cord blood cannot be tested due to maternal and fetal blood mixing, which may give false positive results. |
| Answer D | Infant serum – FTA-ABS |
| Answer D Explanation | Infant serum FTA-ABS is a treponemal test and non-treponemal test (RPR and VDRL) should be performed on a infant of reactive mother. |
| Answer E | |
| Answer E Explanation | |
| Right Answer | D |
| Explanation | Explanation: All infants born to mothers who have reactive non-treponemal and treponemal test results should be evaluated with a quantitative non-treponemal serologic test (RPR or VDRL) performed on infant serum, because umbilical cord blood can become contaminated with maternal blood and yield a false-positive result. Conducting a treponemal test (i.e., TP-PA, FTA-ABS, EIA, or chemiluminescence assay) on a newborn’s serum is not necessary. Educational Objective: |
| Approved | Yes |
| Keyword | |
| Linked Question | |
| Order in Linked Questions |